Cue Biopharma, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $17.9M | $83.4M | $64.4M |
| FY2022 | $25.6M | $91.3M | $51.6M |
| FY2023 | $24.4M | $61.5M | $48.5M |
| FY2024 | $14.7M | $32.2M | $22.5M |
| FY2025 | $15.8M | $42.2M | $27.1M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $17.9M | $83.4M | $64.4M |
| FY2022 | $25.6M | $91.3M | $51.6M |
| FY2023 | $24.4M | $61.5M | $48.5M |
| FY2024 | $14.7M | $32.2M | $22.5M |
| FY2025 | $15.8M | $42.2M | $27.1M |